Imun therapy today celgene paid 1 billion for 10% of juno, an r/d for cart drugs these drugs manipulate tcells for cancer treatment taug owns 7% of immunotherapy,Dr harnoy,who is developing similar drugs manipulating t cells to fight cancer, he is in phase 2/3 trials several years ahead of juno do the math celgene valued juno with no sales at 10 billion Stella may not be as dumb as some on this board think Taug might be a tad undervalued at .003
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.